Personalized therapy in pain management: where do we stand?

Author： Stamer Ulrike M   Zhang Lan   Stüber Frank  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.6, 2010-06, pp. : 843-864

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Statins in Heart Failure—Where Do We Stand?

By Lyons Kristopher   McVeigh Gary   Harbinson Mark  

Cardiovascular Drugs and Therapy, Vol. 25, Iss. 1, 2011-02 ,pp. : 99-104

Springer Publishing Company

Access to resources Recommend Favorite

Intelligent use of NSAIDs - where do we stand?

By Berger R.G.  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 1, 2001-01 ,pp. : 19-30

Informa Healthcare

Access to resources Recommend Favorite

Mucosal Vaccines: Where Do We Stand?

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 20, 2013-10 ,pp. : 2609-2628

Bentham Science Publishers

Access to resources Recommend Favorite

Protease inhibitors - where do we stand?

By Neumann U.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 8, 2002-08 ,pp. : 394-394

Elsevier

Access to resources Recommend Favorite

New developments in IL-6 dependent biology and therapy: where do we stand and what are the options?

By Kallen K-J.   Galle P.R.   Rose-John S.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 9, 1999-09 ,pp. : 1327-1349

Informa Healthcare

Access to resources Recommend Favorite